Guangzheng Ophthalmology (002524.SZ): Currently, no visual prevention and control products have been developed and produced

Gelonghui, March 29丨An investor asked Guangzheng Ophthalmology (002524.SZ) on the investor interactive platform. Regarding “whether your company researches and produces myopia prevention and control products,” the company replied that the company has not yet developed and produced vision prevention and control products. The company provides patients with myopia prevention and control diagnosis and treatment services and solutions, and has good cooperative relationships with mainstream myopia prevention and control product suppliers.

Gelonghui FinanceMar 29 05:46 ET

Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) 26% Share Price Surge Not Quite Adding Up

Guangzheng Eye Hospital Group Co., Ltd. (SZSE:002524) shareholders are no doubt pleased to see that the share price has bounced 26% in the last month, although it is still struggling to make up recent

Simply Wall StMar 8 17:41 ET

Guangzheng Ophthalmology (002524.SZ): 2023 pre-profit of 8 million yuan to 12 million yuan

Ge Longhui, January 29丨Guangzheng Ophthalmology (002524.SZ) announced the 2023 annual performance forecast. Operating income for the reporting period was 1060 million yuan to 1080 million yuan 767.4446 million yuan, up 38.12% to 40.73% over the same period of the previous year; net profit attributable to shareholders of listed companies was 8 million yuan to 12 million yuan, or -78.1776 million yuan in the same period last year; net profit after deducting non-recurring profit and loss was -4 million yuan to -2 million yuan, compared to -291.681 million yuan for the same period last year; basic per share Earnings of 0.02 yuan to 0.

Gelonghui FinanceJan 29 05:56 ET

Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) Shares May Have Run Too Fast Too Soon

When close to half the companies in the Healthcare industry in China have price-to-sales ratios (or "P/S") below 1.8x, you may consider Guangzheng Eye Hospital Group Co., Ltd. (SZSE:002524) as a stock

Simply Wall StJan 22 23:56 ET

Guangzheng Ophthalmology (002524.SZ): Ophthalmology revenue for the third quarter increased 50% year-on-year

Glonghui, Oct. 24, 丨 Guangzheng Ophthalmology (002524.SZ) said on the investor interactive platform that with the restoration of the special external environment and the deepening of the company's brand and service advantages, the company's ophthalmology sector has continued to improve since this year; the third quarter reported a 50% year-on-year increase in ophthalmology revenue; net profit was positive, and 143% year-on-year.

Gelonghui FinanceOct 24, 2023 02:43 ET

Investors Are Selling off Guangzheng Eye Hospital Group (SZSE:002524), Lack of Profits No Doubt Contribute to Shareholders Three-year Loss

Many investors define successful investing as beating the market average over the long term. But the risk of stock picking is that you will likely buy under-performing companies. We regret to report

Simply Wall StOct 24, 2023 02:09 ET